Evercore ISI Group Initiates Coverage On Kailera Therapeutics with Outperform Rating
Benzinga Newsdesk 6 months ago
NewsInitiationAnalyst Ratings
Evercore ISI Group analyst Umer Raffat initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Outperform rating.
Evercore ISI Group analyst Umer Raffat initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Outperform rating.